Lantern Pharma

LTRN

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-22.22M

EBITDA$-20.59M

EBIT$-20.78M

Pre-tax Income$-18.92M

Net Income$-20.78M

Net Cash$83.9M

Cash Equivalent$11.74M

Total Debt$236.8K

Net Debt$-83.66M

Book Value$28.62M

Net Cash Per Share7.60

Book Value Per Share2.66

Return on Equity (ROE)-98.08%

Return on Assets (ROA)-81.27%

Return on Invested Capital (ROI)-98.08%

Net Profit Marginundefined

Current Ratio5.83

Quick Ratio5.54

Long-Term Debt / Equity0.00